J. Molner AS Logo

J. Molner AS

A CDRO specializing in generic injectable and topical drugs for the North American market.

JML | Nasdaq Baltic

Overview

Corporate Details

ISIN(s):
EE3100109034
LEI:
984500F0KEF52E642E45
Country:
Estonia
Address:
Akadeemia tee 21/5, 12618 Tallinn
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

J. Molner AS is a pharmaceutical contract development and research organization (CDRO) that specializes in generic drug development. The company's core expertise is focused on sterile injectable and dermatology (topical) drugs. It provides a range of services to the global pharmaceutical industry, including analytical chemistry, formulation development, and commercial stability solutions. Originally founded in Estonia in 2015, the company primarily serves clients in the U.S. and Canadian markets, aiming to make generic drugs and topical formulations more accessible.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all J. Molner AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for J. Molner AS

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for J. Molner AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sweden
MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden
ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.